Andrew Craven

Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors

Christopher J. Lunniss, Colin Eldred, Natalie E. Aston et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 35 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Cytochalasan syntheses: Synthesis of (17, 18)-17, 18-dihydroxy-10-(prop-2-YL)-14-methyl-[11]cytochalasa-6(7), 13z, 19E-triene-1, 21-dione; an isomer of aspochalasin C

Andrew Craven, Hazel J. Dyke, Eric J. Thomas · Tetrahedron · 1989 · 24 citations

Natural Sciences, Chemistry, Pharmacology +5

Discovery of a Rapidly Metabolized, Long-Acting β₂Adrenergic Receptor Agonist with a Short Onset Time Incorporating a Sulfone Group Suitable for Once-Daily Dosing

Panayiotis A. Procopiou, Victoria J. Barrett, Keith Biggadike et al. · Journal of Medicinal Chemistry · 2013 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Thrombin inhibitors based on [5,5] trans-fused indane lactams

Martin Pass, Said Abu-Rabie, Andrew Baxter et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 21 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The Squalestatins: Synthesis and Biological Activity of Some C3-Modified Analogs; Replacement of a Carboxylic Acid or Methyl Ester with an Isoelectronic Heterocyclic Functionality

Mark J. Bamford, Chuen Chan, Andrew Craven et al. · Journal of Medicinal Chemistry · 1995 · 14 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15